No Data
Growth 250 fell for the first time in five days, with declines in Astroscope ETC in Emerging Markets on the 2nd.
The Tokyo Stock Exchange Growth Market 250 Index has declined for the first time in five days. This comes after a continuous rise leading up to the previous day, and as there wasn't aggressive buying ahead of the four-day holiday, the drop was limited. Heartsheed <219A.T> and Astroscale Holdings <186A.T> were down, while QPS Research Institute <5595.T> and GENDA <9166.T> were up. Kaulis <153A.T> hit a consecutive limit high. The stock that crashed completely the previous day, Oltz <260A.T>, made a sharp rebound. Provided by Wealths A.
Growth 250 has risen for four consecutive days, and Sanbio has significantly increased = Emerging Markets, Day 1.
The Tokyo Stock Exchange Growth Market 250 Index has risen for four consecutive days. With limited selling demand during the holiday gap, a gradual upward trend is observed. SanBio <4592.T> has significantly increased, and iSpace <9348.T>, Heartseed <219A.T>, and QPS Research Institute <5595.T> have also risen. Kawaris <153A.T>, which is taking measures against unauthorized logins, reached the maximum increase, and Ortz <260A.T>, which had overstated its results, completely matched for the first time in three business days due to an expansion of price limits. Provided by Well.
Stocks with a limit-up or limit-down in the afternoon session.
■Limit Up <135A> VRAIN Solution <260A> Ortz <3139> Lact Japan <323A> Flyer <3341> Japan Pharmacy <3803> Image Information Development <3823> THE WHY HOW COMPANY <3987> Ecomot <4584> Kidswell Bio <5574> ABEJA■Limit Down <5575> Globee *Includes temporary limit up/down (indicative price).
Alt: Correction of the temporary report.
Oltz [Lockup Release Schedule]
■ Ortz <260A> Estimated number of shares to be released: 17,178,800 shares (estimated) Release date: 2025/04/09 Target Shareholders : Estimated shares: Chikaki Yamaka : 6,000,000 shares Vertex Growth Fund II Pte. Ltd. : 2,707,200 shares Industrial Technology Investment
Alt: Financial Report - 11th Term (2024/01/01 - 2024/12/31)